Congressman George Latimer, a Democrat who represents New York’s 16th Congressional District that includes part of Westchester and the Bronx ...

The Department of Homeland Security (DHS) has issued additional guidance clarifying how it can proceed with Small Business ...

The National Institutes of Health (NIH) ended all active Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) funding opportunities. (see NIH’s Notice NOT-OD-26-006) ...

Last week, I had the pleasure of hearing from two women founders in the RIoT network who had just received notices of award for federal commercialization support grants. If you aren’t familiar, the ...

The future of a Small Business Administration grant program is up in the air. That uncertainty isn't good for businesses like ...

The US government invests billions of dollars each year to fund research and development by US small businesses through the Small Business Innovation Research (SBIR) and Small Business Technology ...

CALABASAS, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NTHI), a multi–Phase 2 clinical-stage biotechnology company focused on breakthrough therapies for central ...

WASHINGTON – Due diligence plays a vital role in defending national security and safeguarding the integrity of the U.S. Army’s innovation ecosystem. As the Army Small Business Innovation Research and ...

At a time when space is unmistakably a contested warfighting domain, the United States risks slowing its own progress not because of a lack of technology or talent, but because Congress has failed to ...

SBIR funding was a lifeline. “We couldn’t get money out at that point, but we knew we had this continuity of funding, which was really helpful to be able to not completely panic or have to totally ...

Eleven researchers and three SBIR-backed companies receive new funding aimed at strengthening Puerto Rico’s innovation economy. #NewsismyBusiness - Stay updated with the latest Puerto Rico business ...

“Securing $2.5 million in competitive NIH grants during one of the most uncertain federal funding periods reaffirms the scientific and clinical promise of NEO212,” said Dr. Thomas Chen, CEO and Chief ...